🇺🇸 FDA
Patent

US 11365205

Imidazolidin-2-one compounds as PRMT5 modulators

granted A61PA61P29/00A61P3/00

Quick answer

US patent 11365205 (Imidazolidin-2-one compounds as PRMT5 modulators) held by Aurigene Discovery Technologies Limited expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aurigene Discovery Technologies Limited
Grant date
Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P29/00, A61P3/00, A61P3/04, A61P3/10